Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$5,775,000
Lobbying expense
—
Federal awards
—
Relationships
71
| $150,000 |
| — |
| lobbied by | Nasdaq (formerly Nasdaq Omx Group) | $150,000 | — |
| lobbied by | Dendreon Corp. | $140,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $120,000 | — |
| lobbied by | The Medicines Company | $120,000 | — |
| lobbied by | C.r. Bard Inc. | $120,000 | — |
| lobbied by | Nasdaq (formerly Nasdaq Omx Group) | $120,000 | — |
| lobbied by | Eli Lilly And Company | $120,000 | — |
| lobbied by | Aralez Pharmaceuticals Us Inc (formerly Pozen Inc ) | $120,000 | — |
| lobbied by | C.r. Bard Inc. | $120,000 | — |
| lobbied by | Eli Lilly And Company | $120,000 | — |
| lobbied by | Eli Lilly And Company | $120,000 | — |
| lobbied by | Celgene Corporation | $120,000 | — |
| lobbied by | C.r. Bard Inc. | $120,000 | — |
| lobbied by | C.r. Bard Inc. | $120,000 | — |
| lobbied by | Genentech Inc | $120,000 | — |
| lobbied by | Genentech Inc | $120,000 | — |
| lobbied by | Endo Pharmaceuticals Inc | $120,000 | — |
| lobbied by | C.r. Bard Inc. | $120,000 | — |
| lobbied by | Inc. Auxilium Pharmaceuticals | $110,000 | — |
| lobbied by | Novartis | $100,000 | — |
| lobbied by | C.r. Bard Inc. | $100,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $90,000 | — |
| lobbied by | The Medicines Company | $90,000 | — |
| lobbied by | Endo Pharmaceuticals Inc | $90,000 | — |
| lobbied by | Llc Us Healthcare Supply | $90,000 | — |
| lobbied by | The Medicines Company | $90,000 | — |
| lobbied by | Public Service Enterprise Group | $80,000 | — |
| lobbied by | Prudential Financial Inc | $80,000 | — |
| lobbied by | Public Service Enterprise Group | $80,000 | — |
| lobbied by | Public Service Enterprise Group | $80,000 | — |
| lobbied by | Public Service Enterprise Group | $80,000 | — |
| lobbied by | Public Service Enterprise Group | $80,000 | — |
| lobbied by | Novartis | $80,000 | — |
| lobbied by | Prudential Financial Inc | $80,000 | — |
| lobbied by | Novartis | $80,000 | — |
| lobbied by | Celgene Corporation | $70,000 | — |
| lobbied by | Nasdaq (formerly Nasdaq Omx Group) | $70,000 | — |
| lobbied by | The Medicines Company | $70,000 | — |
| lobbied by | Inc. Merck & Co. | $60,000 | — |
| lobbied by | Inc. Auxilium Pharmaceuticals | $60,000 | — |
| lobbied by | Inc. Care Concepts Louisiana | $60,000 | — |
| lobbied by | Celgene Corporation | $60,000 | — |
| lobbied by | Prudential Financial Inc | $60,000 | — |
| lobbied by | Genentech Inc | $60,000 | — |
| lobbied by | Dendreon Corp. | $60,000 | — |
| lobbied by | Inc. Advaxis | $60,000 | — |